JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib.

Saved in:
Bibliographic Details
Title: JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib.
Authors: Ceccardi A; Department of Internal Medicine and Medical Specialties (DiMI), Università di Genova, Genoa, Italy.; IRCCS Policlinico San Martino, Genoa, Italy., Dameri M; IRCCS Policlinico San Martino, Genoa, Italy., Ravera F; Department of Internal Medicine and Medical Specialties (DiMI), Università di Genova, Genoa, Italy.; IRCCS Policlinico San Martino, Genoa, Italy., Gilardi N; Department of Internal Medicine and Medical Specialties (DiMI), Università di Genova, Genoa, Italy.; IRCCS Policlinico San Martino, Genoa, Italy., Stabile M; Department of Internal Medicine and Medical Specialties (DiMI), Università di Genova, Genoa, Italy.; IRCCS Policlinico San Martino, Genoa, Italy.; Institut Jules Bordet, Bruxelles, Belgium., Lombardo I; Beyond Pharma Ltd., Milan, Italy., Ceresa D; IRCCS Policlinico San Martino, Genoa, Italy., Colombo M; Molecular Pathology Unit, IRCCS Policlinico San Martino, Genoa, Italy., Vigo T; Laboratory of Experimental Neuroscience, IRCCS Policlinico San Martino, Genoa, Italy., Cigolini B; Department of Internal Medicine and Medical Specialties (DiMI), Università di Genova, Genoa, Italy.; IRCCS Policlinico San Martino, Genoa, Italy., Rivoli G; Hematology and Cellular Therapy Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Dragani M; Hematology and Cellular Therapy Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Solimano I; Department of Internal Medicine and Medical Specialties (DiMI), Università di Genova, Genoa, Italy., Garuti A; IRCCS Policlinico San Martino, Genoa, Italy., Bellodi A; IRCCS Policlinico San Martino, Genoa, Italy., Ballestrero A; Department of Internal Medicine and Medical Specialties (DiMI), Università di Genova, Genoa, Italy.; IRCCS Policlinico San Martino, Genoa, Italy., Ferrando L; IRCCS Policlinico San Martino, Genoa, Italy., Zoppoli G; Department of Internal Medicine and Medical Specialties (DiMI), Università di Genova, Genoa, Italy.; IRCCS Policlinico San Martino, Genoa, Italy.
Source: British journal of haematology [Br J Haematol] 2025 Feb; Vol. 206 (2), pp. 758-762. Date of Electronic Publication: 2025 Jan 15.
Publication Type: Letter
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39814683
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ceccardi+A%22">Ceccardi A</searchLink>; Department of Internal Medicine and Medical Specialties (DiMI), Università di Genova, Genoa, Italy.; IRCCS Policlinico San Martino, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Dameri+M%22">Dameri M</searchLink>; IRCCS Policlinico San Martino, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Ravera+F%22">Ravera F</searchLink>; Department of Internal Medicine and Medical Specialties (DiMI), Università di Genova, Genoa, Italy.; IRCCS Policlinico San Martino, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Gilardi+N%22">Gilardi N</searchLink>; Department of Internal Medicine and Medical Specialties (DiMI), Università di Genova, Genoa, Italy.; IRCCS Policlinico San Martino, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Stabile+M%22">Stabile M</searchLink>; Department of Internal Medicine and Medical Specialties (DiMI), Università di Genova, Genoa, Italy.; IRCCS Policlinico San Martino, Genoa, Italy.; Institut Jules Bordet, Bruxelles, Belgium.<br /><searchLink fieldCode="AU" term="%22Lombardo+I%22">Lombardo I</searchLink>; Beyond Pharma Ltd., Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Ceresa+D%22">Ceresa D</searchLink>; IRCCS Policlinico San Martino, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Colombo+M%22">Colombo M</searchLink>; Molecular Pathology Unit, IRCCS Policlinico San Martino, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Vigo+T%22">Vigo T</searchLink>; Laboratory of Experimental Neuroscience, IRCCS Policlinico San Martino, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Cigolini+B%22">Cigolini B</searchLink>; Department of Internal Medicine and Medical Specialties (DiMI), Università di Genova, Genoa, Italy.; IRCCS Policlinico San Martino, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Rivoli+G%22">Rivoli G</searchLink>; Hematology and Cellular Therapy Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Dragani+M%22">Dragani M</searchLink>; Hematology and Cellular Therapy Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Solimano+I%22">Solimano I</searchLink>; Department of Internal Medicine and Medical Specialties (DiMI), Università di Genova, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Garuti+A%22">Garuti A</searchLink>; IRCCS Policlinico San Martino, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Bellodi+A%22">Bellodi A</searchLink>; IRCCS Policlinico San Martino, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Ballestrero+A%22">Ballestrero A</searchLink>; Department of Internal Medicine and Medical Specialties (DiMI), Università di Genova, Genoa, Italy.; IRCCS Policlinico San Martino, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Ferrando+L%22">Ferrando L</searchLink>; IRCCS Policlinico San Martino, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Zoppoli+G%22">Zoppoli G</searchLink>; Department of Internal Medicine and Medical Specialties (DiMI), Università di Genova, Genoa, Italy.; IRCCS Policlinico San Martino, Genoa, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2025 Feb; Vol. 206 (2), pp. 758-762. <i>Date of Electronic Publication: </i>2025 Jan 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39814683
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/bjh.19979
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 758
    Titles:
      – TitleFull: JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ceccardi A
      – PersonEntity:
          Name:
            NameFull: Dameri M
      – PersonEntity:
          Name:
            NameFull: Ravera F
      – PersonEntity:
          Name:
            NameFull: Gilardi N
      – PersonEntity:
          Name:
            NameFull: Stabile M
      – PersonEntity:
          Name:
            NameFull: Lombardo I
      – PersonEntity:
          Name:
            NameFull: Ceresa D
      – PersonEntity:
          Name:
            NameFull: Colombo M
      – PersonEntity:
          Name:
            NameFull: Vigo T
      – PersonEntity:
          Name:
            NameFull: Cigolini B
      – PersonEntity:
          Name:
            NameFull: Rivoli G
      – PersonEntity:
          Name:
            NameFull: Dragani M
      – PersonEntity:
          Name:
            NameFull: Solimano I
      – PersonEntity:
          Name:
            NameFull: Garuti A
      – PersonEntity:
          Name:
            NameFull: Bellodi A
      – PersonEntity:
          Name:
            NameFull: Ballestrero A
      – PersonEntity:
          Name:
            NameFull: Ferrando L
      – PersonEntity:
          Name:
            NameFull: Zoppoli G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2025 Feb
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2141
          Numbering:
            – Type: volume
              Value: 206
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: British journal of haematology
              Type: main
ResultId 1